2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels.

ABSTRACT:

SUBMITTER: Pollyea DA 

PROVIDER: S-EPMC3688062 | biostudies-literature | 2013 Feb

REPOSITORIES: biostudies-literature